医学
肿瘤科
疾病
放化疗
内科学
肺癌
化疗
临床试验
阶段(地层学)
预防性头颅照射
生活质量(医疗保健)
入射(几何)
神经内分泌肿瘤
免疫疗法
癌症
生物
古生物学
物理
护理部
心肌梗塞
传统PCI
光学
作者
Gregory Peter Kalemkerian,Bryan James Schneider
标识
DOI:10.1016/j.hoc.2016.08.005
摘要
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor characterized by early metastatic spread and responsiveness to initial therapy. The incidence of SCLC has been declining in the United States in parallel with the decreasing prevalence of cigarette smoking. Limited stage disease is potentially curable with chemoradiotherapy followed by cranial irradiation. Extensive stage disease is incurable, but systemic chemotherapy can improve quality of life and prolong survival. Nearly all patients relapse with chemoresistant disease. Molecularly targeted therapy has failed to yield convincing clinical benefits. Nevertheless, many biologically rational strategies, including immune checkpoint inhibition, show promise in ongoing clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI